Victoria Tutag Lehr, Pharm.D.
Professor (Clinical)
Office Location
EACPHS, Room 4144
Phone
313-993-7743
Department
Pharmacy Practice
Research website
Victoria Tutag Lehr, Pharm.D.
Degrees and Certifications
- Bachelor of Science, Pharmacy: Ferris State University, Big Rapids, MI 1978
- Doctor of Pharmacy: Wayne State University; Detroit, MI 1987
- Licensure: Pharmacist State of Michigan (active); Preceptor (active);
- State of Michigan Pharmacist Controlled Substance (active)
- Medication Therapy Management Training Program WSU 2015
Positions and Employment
- 2017-Present - Professor (Clinical), Wayne State University
- 2006-2017 - Associate Professor, Wayne State University
- 2000-2006 - Assistant Professor, Wayne State University
- 2003-2006 - Clinical Preceptor, Butler University
- 1993-2000 - Clinical Adjunct Faculty, Wayne State University
- 1991-2000 - Clinical Adjunct Faculty, Ferris State University
Awards and Honors
- 2023 - United Health Care Community Health Equity Challenge 2023
- 2022 - Student Senate faculty award: naloxone in student housing
- 2020 - Faculty of the Year Award from class of 2021
- 2018 - ACCP Research award (2ndplace poster): Lead (Pb) inhibits insulin-activated AKT signaling and reduces glycogen in rat liver.
Professional Memberships
- 2020-present - American Society of Addiction Medicine
- 2016-present - Pediatric Pharmacy Advocacy Group
- 2015-2020 - American Society Health Systems Pharmacists
- 2010-present - Michigan Society of Health Systems Pharmacists
- 2010-present - Oakland County Pharmacists Association
- 2009-present - Michigan Pharmacist Association
- 2006-2020 - American Association of Colleges of Pharmacy
- 2000-present - American College of Clinical Pharmacy
- 1989-2017 - American Society of Hospital Pharmacists
Primary Research Interest
- Pediatric pain assessment and management
- Opioid overdose prevention
- Adverse drug reactions
- Lead and hepatic effects in children
Funded Research (Last 5 Years)
- Michigan Department Health and Human Services (MDHHS-MODA) (07/24/2023-08/31/23) $ 97,440 Role: PI 36% effort NaloxBox pilot project for public access naloxone in metropolitan Detroit communities
- Student Success Learning Community Program-Wayne State University (08/15/2023-04/30/2024) $5,000.00/academic year Role: Co-Coordinator (Co-I)
- HRSA Graduate Psychology Education Program grant Vhs Children’s Hospital of Michigan D4033377 (9/1/2022 – 8/30/2025) $ 260,363.00 PI: J. Meade, Ph.D. Role: Consultant; 3% Clinical Psychology Internship Training in Behavioral Health Care
- MiCCSI Michigan Overdose Action (MODA-year 3) Buprenorphine availability in Michigan community pharmacies (09/01/22-08/31/22) $69,500 Role: Co-PI 5%
- MiCCSI Michigan Overdose Action (MODA-year 2) Pharmacist training on buprenorphine and opioid use disorder (09/01/21-08/31/22) $225,000 Role: Co-PI 5%
- MiCCSI/MDHHS Injury and Violence Prevention Unit (MODA-year 1) (6/1/20-12/31/20) $64,536 Role: PI Michigan Pharmacists Buprenorphine knowledge
- Amerisource Bergen Opioid Resource Grant Program (01/31/2020-09/28/2021) $79,849.00 Role: Co-I 10% Pharmacists CARE Program in Dependence and Recovery
- HRSA Graduate Psychology Education Program grant Vhs Children’s Hospital of Michigan (9/1/2019 – 8/31/2022) $ 585,400 PI: J. Meade, Ph.D. Role: Consultant; 2.5% (Extension 2/08/22) Clinical Psychology Internship Training in Behavioral Health Care for High Need Populations
- MDHHS Injury and Violence Prevention Unit (4/01/2019-8/31/2019) $59,998.00 Role: PI 10% Naloxone and Responsiveness of Michigan Pharmacists
Recent Publications
Authored
- Tutag Lehr V, Lulic-Botica M, Golombek S, Aranda JV. Analgesia and sedation in the newborn infant. In: Ramasethu J, Rais-Bahrami K, eds. Atlas of Procedures in Neonatology. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2024:41-49 (in press).
- Tutag Lehr V, Potts G, Lulic-Botica M. Topical Medications for Pediatric Dermatologic Conditions. In: Aranda JV, VandenAnker J, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2021:251-270.
- Chemtob S, Reese J, Lapointe A, Nadeau-Vallee M, Tutag Lehr V. Nonsteroidal anti-inflammatory drugs. In: Aranda JV, Vande Anker J, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2021:553-585.
- Tutag Lehr V, Williams M. Pediatric Anticonvulsants. In: Aranda JV, Vande Anker J, eds. Pediatric Pharmacology: Therapeutic Principles in Practice. 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2021:473-498
- Tutag Lehr V, Lulic-Botica M, Valencia GB, Calo J, Aranda JV. Analgesia and sedation in the newborn infant. In: Ramasethu J, Rais-Bahrami K, eds. Atlas of Procedures in Neonatology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2019:1-7.
Refereed Journals
- Tutag V, Arfken CL. The Revised CDC Chronic Pain Guidelines and Payer Opioid Analgesic Policies in Michigan. MI J Public Health 2024 (in press May 2024).
- Penny B, Agnihotri SK, Tutag Lehr V. Evaluation of a Peer-Led Pharmacy Learning Community 2019-2023. The Learning Assistance Review 2024; 28(3):113-137.
- Tutag Lehr V, Nolan C. Community Pharmacists' Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder [published online ahead of print, 2023 Jan 6]. J Addict Med. 2023;10.1097/ADM.0000000000001135.
- Obarzanek L, Wu W, Tutag-Lehr V. Opioid Management of Dyspnea at End of Life: A Systematic Review [published online ahead of print, 2022 Nov 28]. J Palliat Med. 2022;10.1089/jpm.2022.0311. doi:10.1089/jpm.2022.0311
- Mohammad IN, Berry D, Tutag Lehr V. Opioid Use Disorder care during COVID-19:call for action. JACCP 2021; 11. doi 10.1002/jac5.1556
- Arfken C, Tutag Lehr V. Commercial and public payer opioid analgesic prescribing policies: a case study. Substance Abuse Treatment, Prevention, and Policy 2021; 16:4 https://doi.org/10.1186/s13011-020-00340-z Impact Factor 2.31
Abstracts Published in Academic Journals
- Arfken CL, Tutag Lehr V. Did commercial and Medicaid opioid analgesic policies change after CDC treatment of chronic pain guidelines was revised? J Mental Health Policy Economics 2023; 26(Suppl 1):S5.
- Tutag Lehr V, Opara O, Tomkinson P, Meloche L. Student pharmacist perceptions of community overdose response training JACCP 2022; 5(12):1482.